Crossmark Global Holdings Inc. lessened its holdings in shares of AptarGroup, Inc. (NYSE:ATR – Free Report) by 18.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 5,628 shares of the industrial products company’s stock after selling 1,282 shares during the period. Crossmark Global Holdings Inc.’s holdings in AptarGroup were worth $901,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in ATR. Atria Investments Inc increased its position in AptarGroup by 42.5% in the 3rd quarter. Atria Investments Inc now owns 4,299 shares of the industrial products company’s stock worth $689,000 after buying an additional 1,283 shares during the period. Capital Performance Advisors LLP acquired a new stake in shares of AptarGroup in the third quarter worth $25,000. Centennial Wealth Advisory LLC bought a new position in AptarGroup during the third quarter worth $204,000. Van ECK Associates Corp raised its stake in AptarGroup by 40.0% during the 3rd quarter. Van ECK Associates Corp now owns 37,849 shares of the industrial products company’s stock valued at $6,345,000 after purchasing an additional 10,815 shares during the last quarter. Finally, Congress Asset Management Co. bought a new stake in AptarGroup in the 3rd quarter valued at $108,239,000. Institutional investors own 88.52% of the company’s stock.
Insider Buying and Selling
In other AptarGroup news, CEO Stephan B. Tanda sold 30,000 shares of AptarGroup stock in a transaction on Monday, October 28th. The stock was sold at an average price of $169.60, for a total transaction of $5,088,000.00. Following the completion of the transaction, the chief executive officer now directly owns 174,118 shares of the company’s stock, valued at approximately $29,530,412.80. This trade represents a 14.70 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert Kuhn sold 200 shares of the company’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $150.18, for a total transaction of $30,036.00. Following the completion of the sale, the chief financial officer now directly owns 65,552 shares in the company, valued at approximately $9,844,599.36. The trade was a 0.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 37,535 shares of company stock worth $6,230,324 in the last 90 days. 1.00% of the stock is owned by company insiders.
Analyst Ratings Changes
Read Our Latest Report on AptarGroup
AptarGroup Stock Performance
NYSE ATR opened at $174.15 on Friday. AptarGroup, Inc. has a twelve month low of $122.29 and a twelve month high of $178.03. The company has a quick ratio of 1.15, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market cap of $11.59 billion, a P/E ratio of 34.96, a PEG ratio of 3.03 and a beta of 0.57. The company’s 50-day simple moving average is $162.49 and its 200 day simple moving average is $151.92.
AptarGroup announced that its board has approved a share buyback program on Thursday, October 10th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the industrial products company to repurchase up to 4.7% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.
AptarGroup Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, November 14th. Stockholders of record on Thursday, October 24th were issued a $0.45 dividend. The ex-dividend date was Thursday, October 24th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 1.03%. AptarGroup’s payout ratio is presently 36.14%.
AptarGroup Profile
AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.
Further Reading
- Five stocks we like better than AptarGroup
- ESG Stocks, What Investors Should Know
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- The Basics of Support and Resistance
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.